MRK vs ORMP
Merck & Company Inc (MRK) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MRK and ORMP stock pages for the full models.
Not investment advice.